CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Nano-OligoMed aims to create hybrid nanomaterials for the effective delivery of therapeutic oligonucleotides. The project fosters international collaboration to develop degradable drug carriers that activate therapeutic functions upon reaching target cells, enhancing treatment efficacy in biomedicine.
Nanotechnology has received widespread attention in the last several decades due to the technological breakthroughs it has enabled across sectors from electronics to medicine.
Towards the great challenges that nanotechnology arise, Nano-OligoMed has the ambition to establish and support a network of international collaboration, enabling a collaborative scientific team to effectively use a diversity of approaches and strategies to generate and test hybrid nanomaterials for the efficient and safe…
UNIVERSITA DEGLI STUDI DI MILANO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Roma
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
UNIVERSITA DEGLI STUDI DI PARMA
Italy, PARMA
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Cerdanyola Del Valles
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Canada, Montreal
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
